VIDEX EC (Bristol-Myers Squibb Company)
Welcome to the PulseAid listing for the VIDEX EC drug offered from Bristol-Myers Squibb Company. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bristol-Myers Squibb Company |
| NON-PROPRIETARY NAME: | didanosine |
| SUBSTANCE NAME: | DIDANOSINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-10-31 |
| END MARKETING DATE: | 0000-00-00 |
VIDEX EC HUMAN PRESCRIPTION DRUG Details:
| Item Description | VIDEX EC from Bristol-Myers Squibb Company |
| LABELER NAME: | Bristol-Myers Squibb Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125(mg/1) |
| START MARKETING DATE: | 2000-10-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0087-6671_efb5b283-1ca5-48a8-9f22-3b242b7d9a64 |
| PRODUCT NDC: | 0087-6671 |
| APPLICATION NUMBER: | NDA021183 |
Other DIDANOSINE Pharmaceutical Manufacturers / Labelers:
